N-O [ECS]

*Previous Articles/Studies 2000-2009

NADA / N-ARACHIDONOYLDOPAMINE* (CB1 Agonist)
NAGly / N-ARACHIDDONOYL GLYCINE* (GPR18 Agonist)
NAPE-PLD* (Enzyme Involved in Creating Endocannabinoids)
NARAS / N-ARACHIDONOYL-L-SERINE* (Binds very weakly to Cannabinoid CB1 and CB2)
OEA / OLEOYLETHANOLAMIDE* (Anandamide Analog, GPR119 Agonist)
OLEA / OLEAMIDE (CB1 Agonist)
OMEGA-3 / CB1 CONNECTION* (Without Omega-3, new CB1 Receptors are Made Imperfectly, See Also NUTRITION-HEMP SEED OIL, CBR-CB1 Receptors)
OMEGA-6 / ENDOCANNABINOID CONNECTION* (Some Endocannabinoids are Made From Omega 6, You Need It, But It Is Pro-Inflammatory; Too Much Is Not Good For You. Most Folks Get Too Much)
OMEGA-9


NADA / N-ARACHIDONOYLDOPAMINE
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes (full–2012) http://ajpgi.physiology.org/content/302/8/G873.long
The endocannabinoid system: an overview (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303140/
The endocannabinoid N-arachidonoyldopamine (NADA) exerts neuroprotective effects after excitotoxic neuronal damage via cannabinoid receptor 1 (CB(1)) (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22186081
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (full–2014) http://www.jbc.org/content/early/2014/03/18/jbc.M113.536953.long
Vascular targets for cannabinoids: animal and human studies (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
Effect of N-Arachidonoyl Dopamine on Activity of Neuronal Network in Primary Hippocampus Culture upon Hypoxia Modelling (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24771427
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24644287
Vascular targets for cannabinoids: animal and human studies (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
Effect of N-Arachidonoyl Dopamine on Activity of Neuronal Network in Primary Hippocampus Culture upon Hypoxia Modelling (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24771427
Hypoximimetic activity of N-acyl-dopamines. N-arachidonoyl-dopamine stabilizes HIF-1α protein through a SIAH2-dependent pathway (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25090972
Capsaicin and N-Arachidonoyl-dopamine (NADA) Decrease Tension by Activating Both Cannabinoid and Vanilloid Receptors in Fast Skeletal Muscle Fibers of the Frog (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25228331
Endocannabinoids modulate human blood-brain barrier permeability in vitro (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13106/full
A cannabinoid receptor agonist N-arachidonoyl dopamine inhibits adipocyte differentiation in human mesenchymal stem cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428713/


NAGly / N-ARACHIDDONOYL GLYCINE
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865488/
N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931560/
Toxicology studies with N-acetylglycine (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20188778
Resolution of inflammation by N-arachidonoylglycine (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196844/
siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl glycine-induced cell migration (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493281/
Δ9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01497.x/full
N-arachidonoyl glycine induces macrophage apoptosis via GPR18 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22266325
N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533477/
A GPR18-based signaling system regulates IOP in murine eye (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687663/
The Novel Endocannabinoid Receptor GPR18 is Expressed in the Rostral Ventrolateral Medulla and Exerts Tonic Restraining Influence on Blood Pressure (full–2014) http://jpet.aspetjournals.org/content/early/2014/01/15/jpet.113.209213.long
Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18 (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877838/
Vascular targets for cannabinoids: animal and human studies (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
The cannabinoid acids, analogs and endogenous counterparts (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24731541
Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24751709
Activation of GPR18 by Cannabinoid compounds: A tale of biased agonism (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24762058
top


NAPE-PLD
Psychopharmacology of the endocannabinoids: far beyond anandamide (full–2012) http://www.researchgate.net/publication/51201177_Psychopharmacology_of_the_endocannabinoids_far_beyond_anandamide
Of mice and (wo)men: factors influencing successful implantation including endocannabinoids (full–2013) http://humupd.oxfordjournals.org/content/20/3/415.long
Diacylglycerol lipase α knockout mice demonstrate metabolic and behavioral phenotypes similar to those of cannabinoid receptor 1 knockout mice (full–2015) http://journal.frontiersin.org/article/10.3389/fendo.2015.00086/full
Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382707/
Homeostatic regulation of brain functions by endocannabinoid signaling (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468750/
Endocannabinoids (article–2015) http://emedicine.medscape.com/article/1361971-overview#showall
Endocannabinoid and ceramide levels are altered in patients with colorectal cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25975960


NARAS / N-ARACHIDONOYL-L-SERINE
Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936832/
Angiogenesis: a new physiological role for N-arachidonoyl serine and GPR55? (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936831/
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865488/
N-arachidonoyl–serine is neuroprotective after traumatic brain injury by reducing apoptosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170948/
N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734775/
Vascular targets for cannabinoids: animal and human studies (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury (full–2015) http://tinyurl.com/ochpq54


OEA / OLEOYLETHANOLAMIDE
The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900249/?tool=pubmed
Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls (full–2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.00787.x/full
Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868848/?tool=pubmed
Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women (full–2010) http://www.nutritionandmetabolism.com/content/7/1/49
Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma (full–2010) http://www.jlr.org/content/51/6/1416.full.pdf+html
CD36 gene deletion decreases oleoylethanolamide levels in small intestine of freefeeding mice (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846762/?tool=pubmed
N-Acylethanolamine Levels and Expression of Their Metabolizing Enzymes during Pregnancy (full–2010) http://endo.endojournals.org/content/151/8/3965.full
Endocannabinoids and Human Sperm Cells (link to PDF–2010) http://www.mdpi.com/1424-8247/3/10/3200
Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20353771
Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19954948
Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20100574
Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea-specific role of oleoylethanolamide (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20429051
From surface to nuclear receptors: the endocannabinoid family extends its assets (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20166922
Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136458/?tool=pubmed
Sympathetic activity controls fat-induced oleoylethanolamide signaling in small intestine (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084524/?tool=pubmed
Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111743/?tool=pubmed
Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice (full–2011) http://www.nutritionandmetabolism.com/content/8/1/51
Anandamide and its congeners inhibit human plasma butyrylcholinesterase. Possible new roles for these endocannabinoids? (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21664223
Gut fat sensing in the negative feedback control of energy balance–recent advances (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21557957
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full–2012) http://www.jneuroinflammation.com/content/9/1/79
The endocannabinoid system: an overview (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303140/
Dynamic changes to the endocannabinoid system in models of chronic pain (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3300.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01889.x/pdf
The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423238/
Endocannabinoids measurement in human saliva as potential biomarker of obesity (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409167/?tool=pubmed
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457074/
The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fearconditioned analgesia and controls fear expression in the presence of nociceptive tone (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423235/
G-Protein-Coupled Receptors in Intestinal Chemosensation (full–2012) http://www.sciencedirect.com/science/article/pii/S1550413112000198
Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442338/
Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02042.x/pdf
The Volitional Nature of Nicotine Exposure Alters Anandamide and Oleoylethanolamide Levels in the Ventral Tegmental Area (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572454/
Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study (full–2012) http://press.endocrine.org/doi/full/10.1210/jc.2011-3018
Temporal changes in N-acylethanolamine content and metabolism throughout the periadolescent period (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510355/
Stimulating beta cell replication and improving islet graft function by GPR119 agonists (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1432-2277.2011.01332.x/full
Synthesis of oleoylethanolamide using lipase (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22121828
Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22480617
Optimized synthesis and characterization of N-acylethanolamines and Oacylethanolamines, important family of lipid-signalling molecules (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22850591?dopt=Abstract
Plasma concentrations of endocannabinoids and related primary Fatty Acid amides in patients with post-traumatic stress disorder (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062741
Anandamide Levels Fluctuate in the Bovine Oviduct during the Oestrous Cycle (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0072521
Voluntary Running in Young Adult Mice Reduces Anxiety-Like Behavior and Increases the Accumulation of Bioactive Lipids in the Cerebral Cortex (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0081459
Fatty Acid Modulation of the Endocannabinoid System and the Effect on Food Intake and Metabolism (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677644/
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752332/
Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060040
Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice (full–2013) http://atvb.ahajournals.org/content/33/2/215.long
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers (full–2013) http://www.hindawi.com/journals/ije/2013/259676/
Circulating endocannabinoids in insulin sensitive vs. Insulin resistant obese postmenopausal women. A MONET group study (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/oby.20498/full
Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain- Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874007/
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/
Elevated Anandamide and Related N-Acylethanolamine Levels Occur in the Peripheral Blood of Women With Ectopic Pregnancy and Are Mirrored by Changes in Peripheral Fatty Acid Amide Hydrolase Activity (full–2013) http://press.endocrine.org/doi/full/10.1210/jc.2012-3390
Brain Molecules and Appetite: The Case of Oleoylethanolamide (link to PDF–2013) http://www.eurekaselect.com/107948/article
Biosynthetic Pathways of Bioactive N-Acylethanolamines in Brain (link to PDF–2013) http://www.eurekaselect.com/107971/article
Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23340219
Taste sensitivity to 6-n-propylthiouracil is associated with endocannabinoid plasma levels in normal-weight individuals (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23398921
Alterations in the endocannabinoid system in the rat valproic acid model of autism (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23643692
Detection of the endocannabinoid metabolome in human plasma and breast milk (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/45.8?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Quantification of endocannabinoids in postmortem brain of schizophrenic subjects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23800614
Analysis of the “endocannabinoidome” in peripheral tissues of obese Zucker rats. (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23830028
Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23340219
Exogenous Delta9-Tetrahydrocannabinol Influences Circulating Endogenous Cannabinoids in Humans (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23899642
The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23959001
Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23992544
Plasma Anandamide and Related N-acylethanolamide Levels are not Elevated in Pregnancies Complicated by Hyperemesis Gravidarum (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24117326
The endocannabinoid system mediates aerobic exercise-induced antinociception in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24148812
Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24140894
Brain Region-Specific Changes in N-Acylethanolamine Contents with Time of Day (abst–2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12495/abstract
Effects of Acute Stress on Cardiac Endocannabinoids, Lipogenesis, and Inflammation in Rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24367128
The Effect of Mifepristone (RU486) on the Endocannabinoid System in Human Plasma and First Trimester Trophoblast of Women undergoing Termination of Pregnancy (abst–2013) http://press.endocrine.org/doi/abs/10.1210/jc.2013-2922?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&
Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882055/
Antidepressants and Changes in Concentration of Endocannabinoids and Nacylethanolamines in Rat Brain Structures (full–2014) http://download.springer.com/static/pdf/559/art%253A10.1007%252Fs12640-014-9465-0.pdf?auth66=1395868546_998a8d5d87cb02529572689ff9213e4a&ext=.pdf
Vascular targets for cannabinoids: animal and human studies (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996326/
A role for oleoylethanolamide in chronic lymphocytic leukemia (full–2014) http://www.nature.com/leu/journal/v28/n7/full/leu201410a.html
Dietary Non-Esterified Oleic Acid Decreases the Jejunal Levels of Anorectic Nacylethanolamines (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100365
Classical endocannabinoid-like compounds and their regulation by nutrients (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24677570
Role of anorectic N-acylethanolamines in intestinal physiology and satiety control with respect to dietary fat (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24681513
New players in the fatty acyl ethanolamide metabolism (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747663
Ultramicronized palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24818658
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24874648
Anti-atherosclerosis role of N-oleoylethanolamine in CB2 (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24961101
The FAAH inhibitor PF-04457845 has THC-like rewarding and reinstatement effects in squirrel monkeys and increases dopamine levels in the nucleus accumbens shell in rats (abst–2014) http://www.fasebj.org/content/28/1_Supplement/838.6.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf
Mechanisms of Exercise-Induced Hypoalgesia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25261342
Oleic acid content of a meal promotes oleoylethanolamide response and reduces subsequent energy intake in humans (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25347552
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25413674
A quantitiative LC-MS/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25436483
top
Changes in Plasma Levels of N-Arachidonoyl Ethanolamine and NPalmitoylethanolamine following Bariatric Surgery in Morbidly Obese Females with Impaired Glucose Homeostasis (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/25874237
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection (full–2015) http://www.molecularneurodegeneration.com/content/pdf/s13024-015-0012-0.pdf
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa (full–2015) http://ajcn.nutrition.org/content/101/2/262.long
Endocannabinoids modulate human blood-brain barrier permeability in vitro (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13106/full
Fat Diet-Induced Insulin Resistance Does Not Increase Plasma Anandamide Levels or Potentiate Anandamide Insulinotropic Effect in Isolated Canine Islets (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0123558
Dietary Triacylglycerols with Palmitic Acid in the sn-2 Position Modulate Levels of NAcylethanolamides in Rat Tissues (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361611/
Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 (CB1 ) receptors located on glutamatergic neurons and on astrocytes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25626460
Involvement of norepinephrine and serotonin system in antidepressant-like effects of oleoylethanolamide in the mice models of behavior despair (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25778418
Intestinal lipid-derived signals that sense dietary fat (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25642767
Anandamide Drives Cell Cycle Progression through CB1 Receptors in a Rat Model of Synchronized Liver Regeneration (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25684344
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer’s Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818503
Simultaneous determination of endocannabinoids in murine plasma and brain substructures by surrogate-based LC-MS/MS: Application in tumor-bearing mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863017
Antidepressant-like Effects of Oleoylethanolamide in a Mouse Model of Chronic Unpredictable Mild Stress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25864425
Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies. (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25917763
Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26180248
COMPARATIVE EFFECTS OF PARATHION AND CHLORPYRIFOS ON ENDOCANNABINOID AND ENDOCANNABINOID-LIKE LIPID METABOLITES IN RAT STRIATUM (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26215119


OLEA / OLEAMIDE
Oleamide administered into the nucleus accumbens shell regulates feeding behaviour via CB1 and 5-HT2C receptors (full–2010)
http://ijnp.oxfordjournals.org/content/13/9/1247.long
Pitfalls in the sample preparation and analysis of N-acylethanolamines (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936757/
Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20056119
Enhanced vasorelaxant effects of the endocannabinoid-like mediator, oleamide, in hypertension (full–2012) http://www.sciencedirect.com/science/article/pii/S0014299912002671
Oleamide restores sleep in adult rats that were subjected to maternal separation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22975223
2-Arachidonoylglycerol into the lateral hypothalamus improves reduced sleep in adult rats subjected to maternal separation (abst–2014)
http://www.ncbi.nlm.nih.gov/pubmed/25356522
Endocannabinoids modulate human blood-brain barrier permeability in vitro (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13106/full
Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/25641667
Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25660201


OMEGA-3 / CB1 CONNECTION
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930808/?tool=pubmed
Maternal Dietary Fat Determines Metabolic Profile and the Magnitude of Endocannabinoid Inhibition of the Stress Response in Neonatal Rat Offspring (full–2010) http://endo.endojournals.org/content/151/4/1685.full?sid=f9729cff-d221-42d4-81d8-8545db5df878
Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma (full–2010) http://www.jlr.org/content/51/6/1416.full.pdf+html
Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20013888
Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice (full–2011) http://www.nutritionandmetabolism.com/content/8/1/51
Fish oil promotes survival and protects against cognitive decline in severely undernourished mice by normalizing satiety signals (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117120/
A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215906/
Greasing the wheels of managing overweight and obesity with omega-3 fatty acids (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210336/
Hepatic n-3 Polyunsaturated Fatty Acid Depletion Promotes Steatosis and Insulin Resistance in Mice: Genomic Analysis of Cellular Targets (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154437/
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21278728
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Figure 1: n-3/n-6 PUFA dietary imbalance alters PUFAs level in mouse brain (charts–2011) http://www.nature.com/neuro/journal/v14/n3/fig_tab/nn.2736_F1.html
Endocannabinoid signaling and energy metabolism: a target for dietary intervention (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21470818
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21995886
Endocannabinoids: A healthy diet is good for LTD (news–2011) http://www.lipidmaps.org/update/2011/110301/full/nrn2998.html
Omega-3 Fatty Acids Essential for Normal Regulation of Mood in the Brain (news–2011) http://www.elements4health.com/omega-3-fatty-acids-essential-for-normal-regulation-of-mood-in-thebrain.html
A Summary of Endocannabinoids and Obesity (news–2011) http://evolutionarypsychiatry.blogspot.com/2011/04/summary-of-endocannabinoids-and-obesity.html
Omega-3 deficiency disrupts cannibinoid receptor function in brain (news–2011) http://www.wellsphere.com/general-medicine-article/omega-3-deficiency-disrupts-cannibinoid-receptorfunction-in-brain/1347465
What An Expectant Mother Eats Affects Children’s Psychology in Later Life (news–2011) http://nanopatentsandinnovations.blogspot.com/2011/01/what-expectant-mother-eats-affects.html
A Brain Wrought Without Omega-3 (news–2011) http://www.schizophreniaforum.org/new/detail.asp?id=1646
Poor Diet Impairs Cannabinoid Receptors (news–2011) http://www.freedomisgreen.com/poor-diet-impairs-cannabinoid-receptors/
Scientific research reveals brain alterations linking omega 3 deficit with depression (news–2011) http://www.alphagalileo.org/ViewItem.aspx?ItemId=95297&CultureCode=en
Research provides new clues to understand link between deficits of AGPO-3, depression (news – 2011) http://www.news-medical.net/news/20110205/Research-provides-new-clues-to-understand-link-betweendeficits-of-AGPO-3-depression.aspx
Why Omega-3s Affect Your Mood (news–2011) http://voices.yahoo.com/why-omega-3s-affect-mood-8180941.html?cat=5
Functional Metabolomics Reveals Novel Active Products in the DHA Metabolome (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342038/?tool=pubmed
Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372498/
Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458187/
Type 2 Diabetes Associated Changes in the Plasma Non-Esterified Fatty Acids, Oxylipins and Endocannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493609/
Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483099/
Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372498/
Searching for health beneficial n-3 and n-6 fatty acids in plant seeds. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380567/
N-acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids – From fishy endocannabinoids to potential leads (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/bph.12030/full
Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L) and mice, and induces weight gain and inflammation in mice (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548985/
Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice (abst–2012) http://www.springerlink.com/content/ur5784gm34782505/
Essential fatty acids and lipid mediators. Endocannabinoids (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22730630
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators. (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23103355
Effect of omega-3 polyunsaturated fatty acids on the endocannabinoid system in osteoblast-like cells and muscle (abst–2012) http://docs.lib.purdue.edu/dissertations/AAI3444794/
Acetaminophen, pesticide, and diethylhexyl phthalate metabolites, anandamide, and fatty acids in deciduous molars: potential biomarkers of perinatal exposure (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22805989
Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22051448
Cannabinoid Receptor Function is Altered by Nutritionally Deficient Diet (news–2012) http://www.examiner.com/medical-marijuana-in-philadelphia/cannabinoid-receptor-function-is-altered-bynutrionally-deficient-diet
Effect of dietary fat type on anxiety-like and depression-like behavior in mice (full–2013) http://www.springerplus.com/content/2/1/165
Fatty Acid Modulation of the Endocannabinoid System and the Effect on Food Intake and Metabolism (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677644/
Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men (full–2013) http://www.lipidworld.com/content/12/1/78
Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541447/
Voluntary Running in Young Adult Mice Reduces Anxiety-Like Behavior and Increases the Accumulation of Bioactive Lipids in the Cerebral Cortex (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0081459
Nutritional properties of dietary omega-3-enriched phospholipids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747496/
Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648912/
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury (full–2013) http://www.sciencedirect.com/science/article/pii/S0306452213007835
DHA prevents altered 5-HT1(A), 5-HT2(A), CB1 and GABA(A) receptor binding densities in the brain of male rats fed a high-saturated-fat diet (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23337348
Fat to treat fat: Emerging relationship between dietary PUFA, endocannabinoids, and obesity (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23466458
PUFA-derived endocannabinoids: an overview (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24020830
Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24020800
Differential Modulation of Tumor Cell Proliferation and their Endocannabinoid System by Polyunsaturated Fatty Acids (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24138715
Acyl migration evaluation in monoacylglycerols from Echium plantagineum seed oil and Marinol (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23287502
top
Endogenous Signaling by Omega-3 Docosahexaenoic Acid-derived Mediators Sustains Homeostatic Synaptic and Circuitry Integrity (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180614/
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24518289
Hempseed oil induces reactive oxygen species- and C/EBP homologous protein-mediated apoptosis in MH7A human rheumatoid arthritis fibroblast-like synovial cells (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24814038
Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24854955
Cannabinoid-free Cannabis sativa L. grown in the Po valley: evaluation of fatty acid profile, antioxidant capacity and metabolic content (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24934168
Docosahexaenoic acid, G protein-coupled receptors, and melanoma: is G protein-coupled receptor 40 a potential therapeutic target? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24576779
Cannabinoid receptor expression in femora and tibiae of C57/blk6 mice fed DHA and relationship to bone ash and BMC (bone mineral content) (abst–2014) http://www.fasebj.org/content/28/1_Supplement/1032.2.abstract?sid=467bb529-0ecc-4ddc-af27-3f56f520a102
Potential Oil Yield, Fatty Acid Composition, and Oxidation Stability of the Hempseed Oil from Four Cannabis sativa L. Cultivars (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24552275
Endocannabinoid signaling and its regulation by nutrients (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24753395
Hempseed oil induces reactive oxygen species- and C/EBP homologous protein-mediated apoptosis in MH7A human rheumatoid arthritis fibroblast-like synovial cells (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24814038
Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24854955
Cannabinoid-free Cannabis sativa L. grown in the Po valley: evaluation of fatty acid profile, antioxidant capacity and metabolic content (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24934168
Cannabinoid receptor expression in femora and tibiae of C57/blk6 mice fed DHA and relationship to bone ash and BMC. (bone mineral content) (abst–2014) http://www.fasebj.org/content/28/1_Supplement/1032.2.abstract?sid=467bb529-0ecc-4ddc-af27-3f56f520a102
Relationship between cannabinoids content and composition of fatty acids in hempseed oils (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25306338
Omega-3 fatty acid production from enzyme saccharified hemp hydrolysate using a novel marine thraustochytrid strain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25497057
Plant-Based Foods With the Highest Omega-3 Fatty Acids (news–2014) http://www.onegreenplanet.org/natural-health/plant-based-foods-with-the-highest-amount-of-omega-3-fatty-acids/
Inhibition of COX-2-mediated eicosanoid production plays a major role in the antiinflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.12747/full
The endocannabinoid system: directing eating behavior and macronutrient metabolism (full–2015) http://journal.frontiersin.org/Journal/10.3389/fpsyg.2014.01506/full
Distribution of Bioactive Lipid Mediators in Human Skin (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25668241
Diet-induced changes in n-3 and n-6 derived endocannabinoids and reductions in headache pain and psychological distress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25958314
Dietary DHA reduced downstream endocannabinoid and inflammatory gene expression, epididymal fat mass, and improved aspects of glucose use in muscle in C57BL/6J mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26219414
Hemp for a Healthy Heart? (news–2015) http://blog.lifeextension.com/2014/02/hemp-for-healthy-heart.html
The Benefits of Organic Hemp Milk (news-2015) http://www.globalhealingcenter.com/natural-health/benefits-of-hemp-milk/


OMEGA-6 / ENDOCANNABINOID CONNECTION
Exposure to a high-fat diet decreases sensitivity to Δ9-tetrahydrocannabinol-induced motor effects in female rats (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014410/
Hepatic n-3 Polyunsaturated Fatty Acid Depletion Promotes Steatosis and Insulin Resistance in Mice: Genomic Analysis of Cellular Targets (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154437/
Endocannabinoid signaling and energy metabolism: a target for dietary intervention. (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21470818
A Summary of Endocannabinoids and Obesity (news–2011) http://evolutionarypsychiatry.blogspot.com/2011/04/summary-of-endocannabinoids-and-obesity.html
Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L) and mice, and induces weight gain and inflammation in mice (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548985/
Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458187/
Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483099/
N-acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids – From fishy endocannabinoids to potential leads (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/bph.12030/full
Searching for health beneficial n-3 and n-6 fatty acids in plant seeds (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380567/
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators. (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23103355
Voluntary Running in Young Adult Mice Reduces Anxiety-Like Behavior and Increases the Accumulation of Bioactive Lipids in the Cerebral Cortex (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0081459
Dietary Linoleic Acid Elevates the Endocannabinoids 2-AG and Anandamide and Promotes Weight Gain in Mice Fed a Low Fat Diet (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889814/
Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648912/
PUFA-derived endocannabinoids: an overview (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24020830
Impact of omega-6 polyunsaturated fatty acid supplementation and γ-aminobutyric acid on astrogliogenesis through the endocannabinoid system (abst–2013) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23231/abstract
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24518289
Docosahexaenoic acid, G protein-coupled receptors, and melanoma: is G protein-coupled receptor 40 a potential therapeutic target? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24576779
Gamma-linolenic acid egg production enriched with hemp seed oil and evening primrose oil in diet of laying hens (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25004746
Cannabinoid-free Cannabis sativa L. grown in the Po valley: evaluation of fatty acid profile, antioxidant capacity and metabolic content (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24934168
Relationship between cannabinoids content and composition of fatty acids in hempseed oils (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25306338
Plant-Based Foods With the Highest Omega-3 Fatty Acids (news–2014) http://www.onegreenplanet.org/natural-health/plant-based-foods-with-the-highest-amount-of-omega-3-fatty-acids/
The endocannabinoid system: directing eating behavior and macronutrient metabolism (full–2015) http://journal.frontiersin.org/Journal/10.3389/fpsyg.2014.01506/full
Diet-induced changes in n-3 and n-6 derived endocannabinoids and reductions in headache pain and psychological distress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25958314
Dietary DHA reduced downstream endocannabinoid and inflammatory gene expression, epididymal fat mass, and improved aspects of glucose use in muscle in C57BL/6J mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26219414
The Benefits of Organic Hemp Milk (news-2015) http://www.globalhealingcenter.com/natural-health/benefits-of-hemp-milk/


OMEGA-9
Pitfalls in the sample preparation and analysis of N-acylethanolamines (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936757/
Targeted mutation of Δ12 and Δ15 desaturase genes in hemp produce major alterations in seed fatty acid composition including a high oleic hemp oil (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/pbi.12167/epdf
Your Next Cooking Oil Could Come From Hemp (news–2014) http://www.popsci.com/article/science/your-next-cooking-oil-could-come-hemp
top